We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+0.06%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$147M
AUM Growth
+$29.5M
Cap. Flow
+$30.7M
Cap. Flow %
20.86%
Top 10 Hldgs %
20.1%
Holding
558
New
454
Increased
48
Reduced
28
Closed
5

Top Buys

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$2.09M
2
LNCE
Snyders-Lance, Inc.
LNCE
+$1.97M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.83M
4
CB
CHUBB CORPORATION
CB
+$1.64M
5
AHL
ASPEN Insurance Holding Limited
AHL
+$1.55M

Top Sells

Rank Stock Value
1
STE icon
Steris
STE
+$1.3M
2
AZZ icon
AZZ Inc
AZZ
+$708K
3
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$299K
4
SMB icon
VanEck Short Muni ETF
SMB
+$211K
5
CVS icon
CVS Health
CVS
+$71.4K

Sector Composition

Rank Sector Weight
1 Consumer Staples 19.81%
2 Financials 15.28%
3 Healthcare 14.73%
4 Industrials 8.26%
5 Consumer Discretionary 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUMN icon
526
Lumen
LUMN
$6.57B
$0 ﹤0.01%
+17
New +$579
NBIX icon
527
Neurocrine Biosciences
NBIX
$16.8B
$0 ﹤0.01%
+8
New +$339
NGVC icon
528
Vitamin Cottage Natural Grocers
NGVC
$739M
$0 ﹤0.01%
+39
New +$999
NOAH
529
Noah Holdings
NOAH
$580M
$0 ﹤0.01%
+2
New +$65
PCRX icon
530
Pacira BioSciences
PCRX
$1.04B
$0 ﹤0.01%
+10
New +$788
RARE icon
531
Ultragenyx Pharmaceutical
RARE
$2.45B
$0 ﹤0.01%
+5
New +$388
SAP icon
532
SAP
SAP
$212B
$0 ﹤0.01%
+14
New +$1.04K
SHY icon
533
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$0 ﹤0.01%
+8
New +$679
SJNK icon
534
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
– –
-10,250
Closed -$299K
SMB icon
535
VanEck Short Muni ETF
SMB
$312M
– –
-12,000
Closed -$211K
SNCR
536
DELISTED
Synchronoss Technologies
SNCR
$0 ﹤0.01%
+2
New +$860
STE icon
537
Steris
STE
$22.3B
– –
-18,500
Closed -$1.3M
TENX icon
538
Tenax Therapeutics
TENX
$363M
– –
0
– –
TNL icon
539
Travel + Leisure Co
TNL
$4.66B
$0 ﹤0.01%
+22
New +$862
TXNM
540
TXNM Energy Inc
TXNM
$6.41B
$0 ﹤0.01%
+39
New +$1.04K
AVTA
541
DELISTED
Avantax, Inc. Common Stock
AVTA
$0 ﹤0.01%
+50
New +$770
CLVS
542
DELISTED
Clovis Oncology, Inc.
CLVS
$0 ﹤0.01%
+4
New +$342
CXP
543
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$0 ﹤0.01%
+25
New +$660
TTPH
544
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$0 ﹤0.01%
+1
New +$818
APU
545
DELISTED
AmeriGas Partners, L.P.
APU
$0 ﹤0.01%
+1
New +$48
ELGX
546
DELISTED
Endologix Inc
ELGX
$0 ﹤0.01%
+5
New +$825
ACTA
547
DELISTED
Actua Corp
ACTA
$0 ﹤0.01%
+1
New +$14
CEMP
548
DELISTED
Cempra, Inc.
CEMP
$0 ﹤0.01%
+17
New +$601
NEFF
549
DELISTED
Neff Corporation
NEFF
$0 ﹤0.01%
+86
New +$959
CPHD
550
DELISTED
Cepheid Inc
CPHD
$0 ﹤0.01%
+14
New +$798
19 20 21
22
23

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Kavar Capital Partners Group's Q2 2015 Portfolio in Review

As of Q2 2015, Kavar Capital Partners Group held 558 positions worth $147M, up 25% from $118M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Kavar Capital Partners Group deployed $30.7M of net new capital in Q2 2015, opening 454 new positions and adding to 48 existing holdings. Its largest new stake was Reynolds American Inc: 55,750 shares worth $2.08M.

By sector, the portfolio is most concentrated in Consumer Staples at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CVS Health, an estimated $71.4K trimmed.

  • Kavar Capital Partners Group's largest Q2 2015 buy was Reynolds American Inc: 55,750 shares worth $2.08M.
  • Kavar Capital Partners Group added most to Target in Q2 2015, an estimated $821K increase.
  • Kavar Capital Partners Group's biggest Q2 2015 reduction was CVS Health, cutting an estimated $71.4K.
  • Kavar Capital Partners Group fully exited Steris in Q2 2015, selling an estimated $1.3M.
  • Kavar Capital Partners Group's ten largest holdings make up 20% of its $147M portfolio in Q2 2015.
  • Kavar Capital Partners Group opened 454 new positions and closed 5 in Q2 2015.
  • Kavar Capital Partners Group's portfolio value rose 25% quarter-over-quarter to $147M.

Based on Kavar Capital Partners Group's 13F filing for Q2 2015, filed 1 May 2019.